The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2% from 2020 to 2027.

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore, maintain, or improve tissue function. In addition, for this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs.

The tissue engineering market is anticipated to grow significantly during the forecast period, owing to increase in prevalence of chronic diseases & trauma emergencies, rise in awareness related to tissue engineering, and potential pipeline products. Furthermore, growth in number of R&D activities with rise in awareness of tissue engineering in emerging economies are expected to support the market growth. Developed nations have adopted technological advancements in tissue engineering and regenerative medicine sectors, which help in expansion of the global market. In addition, increase in focus of key players on tissue engineering based therapies are expected to enhance the tissue engineering market growth during the forecast period. However, stringent government regulations and high cost of treatment are estimated to hamper growth of the market.

Request for a FREE sample of this market research report@

The global tissue engineering market is segmented into type, application, and region. On the basis of type, the market is categorized into synthetic scaffold material, biologically derived scaffold material, and others. The synthetic scaffold material segment is further categorized into synthetic polymer and others. The biologically derived scaffold material segment is bifurcated into collagen and others. On the basis of application, the market is segregated into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

– The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
– It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
– A comprehensive analysis of four regions is provided to determine the existing opportunities.
– The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.


By Product
– Synthetic Scaffold Material
o Synthetic Polymer
o Others
– Biologically Derived Scaffold Material
o Collagen
o Others
– Others
By Application
– Orthopedics & Musculoskeletal
– Neurology
– Cardiovascular
– Skin & Integumentary
– Dental
– Others
By Region
– North America
o U.S.
o Canada
o Mexico
– Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
– Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
o Latin America
o Middle East and Africa

Send a request to Report Ocean to understand the structure of the complete report @

– AbbVie Inc. (Allergen Plc.)
– B. Braun Melsungen AG
– Becton, Dickinson and Company (C. R. BARD, INC.)
– Integra LifeSciences
– Organogenesis Holdings
– Sid Martin Biotech (Axogen)
– Smith & Nephew Plc. (Osiris Therapeutics)
– TissueTech Inc.
– Vericel Corporation
– Zimmer Biomet Holdings, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
– Modex Therapeutics
– Biotime Inc
– Sanofi (Genzyme)